Press Releases

Scipio bioscience Announces Its Revolutionary Asteria© Single-cell RNA-seq Kit and Companion Cytonaut© Analysis Software Are Now Commercially Available

Scipio bioscience has announced that Asteria©, the latest breakthrough single-cell RNA-sequencing kit, is now commercially available for any researcher worldwide.

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

CYTENA has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins.

Biotium Announces Acquisition of CAT5™ FFPE RNA/DNA Extraction Technology from Cell Data Sciences

Biotium is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction.

RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the enrollment of the first patient into its PREMIER registry, a prospective, real-world evidence clinical outcomes registry for patients with all stages of cancer, at the University of Texas (UT) Southwestern in Dallas.

Creative Bioarray Provides Expertise in Delivering Comprehensive Pain Models to Support Pain Studies

Creative Bioarray Supplies Comprehensive Products to Support The Needs of Cell Culture Applications

DDA Platform Delivers Metabolic Stability Services to Accelerate Drug Discovery Procedures

Creative Biogene Generates Professional Cell Expression System to Accelerate Bioproduction Stable Cell Line Development

Qvirus Platform Optimized Lentivirus Production System for The Efficient design and Development of Lentivirus Vector

Microbiosci Develops Strain Selection and Fermentation Services to Accelerate The Development of Microbial Technologies

Drugs and alcohol consumption are the main causes of homelessness

I have been searching about lately. The type of details here on the forum is excellent and helpful and is going to assist my friends and I in our studies a couple times a week. It seems like all of the members here acquired a significant amount of info about this and other subjects and types of info like wise show it. I am not browsing websites most of the time although when I get an opportunity i'm usually avidly searching for this type of knowledge and things closely related to it. When anyone gets a chance, take a look at my website: [url=https://elpasodisabilitylawyer.com/practice-areas/]ssa attorney in san elizario, tx[/url]

CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry

Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.

Alfa Chemistry: Polymer Surfactants Have Exceptional Properties

With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.

CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.

Elligo Launches European Operations to Enable Research Through Healthcare

Elligo Health Research announces collaboration with WHYZE Health — an integration that will break down barriers for participation in clinical trials.

Curebase Secures $40 Million in Series B Funding

Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in Series B funding to continue development of its end-to-end clinical trial execution model, virtual and hybrid site capabilities, and full eClinical software platform to run modern, patient-centric clinical trials.

CSStore is specialized in reselling Cheap Mindjet software online.

Hello, I recently came to the CSStore. They sell Cheap Super Win software, prices are actually low, I read reviews and decided to [url=https://cheapsoftwareshop.com/autodesk-autocad-map-3d-2019/]Buy Cheap Autocad Map 3d 2019[/url], the price difference with the official website is 40%!!! Tell us, do you think this is a good buy? Excellent service, received the Windows 10 Pro code in minutes and it worked smoothly. I would recommend it to everyone. [url=https://cheapsoftwareshop.com/autodesk-artcam-premium-2018/]Buy Cheap Artcam Premium[/url]

Global CRO to Showcase Respiratory Expertise at 2022 ATS International Conference

Rho, a global full-service contract research organization (CRO), will showcase its expertise in pulmonary and respiratory related illnesses with attendees during the 2022 American Thoracic Society (ATS) International Conference, taking place at the Moscone Center in San Francisco, May 13-18. Rho experts will be at booth #2203 to share their knowledge of the latest advances in the rapidly evolving field of pulmonary medicine, some of which include asthma, COPD and cystic fibrosis. They will be available for one-on-one interviews during the conference with those interested in learning more about Rho’s industry developments.

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. This is a significant study given the disease burden of cardiovascular conditions—especially in underserved patients—and the current emphasis on ongoing clinical validation of artificial intelligence and AI-based virtual care solutions. The study—which focuses on populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions. The ACC study includes three arms: • One that focuses on patient education only; • One that leverages the Biofourmis Care solution—including connected devices and medication optimization algorithms—with patient management by local providers; • One that also uses the Biofourmis Care solution + Biofourmis’ frontline virtual health navigators.